About the Product

Description


Tigslide Injection contains Tigecycline (50mg), a broad-spectrum glycylcycline antibiotic used for the treatment of complicated bacterial infections. It is structurally related to tetracyclines but has an expanded spectrum of activity against drug-resistant bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and multidrug-resistant Acinetobacter species.

Tigecycline is effective against a wide range of Gram-positive and Gram-negative bacteria, making it useful in treating infections that are resistant to conventional antibiotics. It works by inhibiting bacterial protein synthesis, preventing bacterial growth and replication.

Tigslide Injection is commonly used in the treatment of complicated intra-abdominal infections (cIAI), complicated skin and soft tissue infections (cSSTI), and community-acquired bacterial pneumonia (CABP). Due to its broad-spectrum efficacy, it is often used in hospital settings where other antibiotics have failed or when a resistant bacterial infection is suspected.

This medication is administered intravenously under medical supervision. It should only be used as prescribed by a healthcare professional, and its dosage is adjusted based on the severity of the infection and patient-specific factors.

Common side effects include nausea, vomiting, diarrhea, headache, injection site reactions, and increased liver enzymes. Serious side effects may include hypersensitivity reactions or Clostridium difficile-associated diarrhea.

Tigslide Injection is indicated for the treatment of complicated intra-abdominal infections, complicated skin and soft tissue infections, and community-acquired bacterial pneumonia.

Tigslide Injection should only be used under medical supervision. Not recommended for patients with severe hepatic impairment or for use in children under 8 years due to potential tooth discoloration.

Store below 25°C, protect from light and moisture. Use reconstituted solution immediately or as per medical guidelines.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Tigecycline 50mg Injection in the PCD pharma franchise market?

Tigecycline 50mg Injection has strong demand in the critical care, infectious disease, hospital care, and intensive care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on advanced injectable antibiotic portfolios.

Why should medical distributors include Tigecycline 50mg Injection in their product range?

Medical distributors and agencies can benefit from consistent demand for serious and complicated bacterial infection management under specialist medical supervision. Tigecycline 50mg is a broad-spectrum glycylcycline antibiotic used in the treatment of certain complicated bacterial infections Commonly prescribed for complicated skin and soft tissue infections, complicated intra-abdominal infections, and other severe infections caused by susceptible bacteria Frequently utilized in ICUs, tertiary care hospitals, emergency departments, and specialty infection management units Often considered in cases involving multidrug-resistant bacterial pathogens as per clinical guidelines and susceptibility reports Widely prescribed by infectious disease specialists, intensivists, surgeons, and physicians This strengthens a comprehensive critical care and anti-infective portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Tigecycline 50mg Injection with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong hospital demand, institutional procurement opportunities, specialty antibiotic usage, reliable supply chain support, and attractive margins in the critical care segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.